EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Harnessing the power of IFN for therapeutic approaches to COVID-19

Elise G Viox iD, Steven E Bosinger, Daniel C Douek, Gideon Schreiber iD, Mirko Paiardini iD

Journal of Virology · 2024

DOI: 10.1128/jvi.01204-23 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Virology, 2024. Verfasst von Elise G Viox und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19, COVID-19 Drug Treatment, Interferons. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: William I. H. and Lula E. Pitts Foundation (William I. H. & Lula E. Pitts Foundation), HHS | National Institutes of Health (NIH), NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interferons (IFNs) are essential for defense against viral infections but also drive recruitment of inflammatory cells to sites of infection, a key feature of severe COVID-19. Here, we explore the complexity of the IFN response in COVID-19, examine the effects of manipulating IFN on SARS-CoV-2 viral replication and pathogenesis, and highlight pre-clinical and clinical studies evaluating the therapeutic efficacy of IFN in limiting COVID-19 severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsCOVID-19COVID-19 Drug TreatmentInterferonsSARS-CoV-2AnimalsHumansVirus Replication

Stichwörter der Autor:innen

COVID-19IFNIFN-IIFN-IIISARS-CoV-2

Substanzen

Antiviral AgentsInterferons

Autor:innen und Institutionen

  • Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, Georgia, USA.
  • Emory NPRC Genomics Core Emory National Primate Research Center, Emory University, Atlanta, Georgia, USA.
  • Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.
  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.

ORCID-Profile: Elise G Viox, Gideon Schreiber, Mirko Paiardini

Förderung

  • William I. H. and Lula E. Pitts Foundation (William I. H. & Lula E. Pitts Foundation)
  • HHS | National Institutes of Health (NIH)
  • NIH HHS
  • Emory University (EU)
  • Fast Grants (Fast Grants from Emergent Ventures)

Zitieren

APA

Viox, E. G., Bosinger, S. E., Douek, D. C., Schreiber, G., & Paiardini, M. (2024). Harnessing the power of IFN for therapeutic approaches to COVID-19. Journal of Virology. https://doi.org/10.1128/jvi.01204-23

Vancouver

Viox EG, Bosinger SE, Douek DC, Schreiber G, Paiardini M. Harnessing the power of IFN for therapeutic approaches to COVID-19. Journal of Virology. 2024. doi:10.1128/jvi.01204-23

BibTeX
@article{Viox2024,
  author = {Viox, Elise G and Bosinger, Steven E and Douek, Daniel C and Schreiber, Gideon and Paiardini, Mirko},
  title = {Harnessing the power of IFN for therapeutic approaches to COVID-19},
  journal = {Journal of Virology},
  year = {2024},
  doi = {10.1128/jvi.01204-23}
}
Kostenlos starten →